European Case Law Identifier: | ECLI:EP:BA:2013:R000613.20131122 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 22 November 2013 | ||||||||
Case number: | R 0006/13 | ||||||||
Petition for review of: | T 0977/09 | ||||||||
Application number: | 01994654.0 | ||||||||
IPC class: | A61K 9/16 A61K 38/46 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | B | ||||||||
Download and more information: |
|
||||||||
Title of application: | Process for the production of microspheres of pancreatic enzymes with high stability | ||||||||
Applicant name: | Aptalis Pharma S.r.l. | ||||||||
Opponent name: | Abbott Products GmbH | ||||||||
Board: | EBA | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Non-admittance of a document - Violation of right to be heard - no Petition for review - clearly unallowable Causal link between the procedural defect and the final decision - no |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/r130006eu1.html
Date retrieved: 17 May 2021